The hypothesis is that treating children with cystic fibrosis with high- dose ibuprofen, anti-inflammatory drug, will result in reduced inflammation in the lung as reflected by lowered levels of specific inflammatory markers and mediators present in bronchoalveolar lavage (BAL) fluid.
Showing the most recent 10 out of 502 publications